A Randomized, Double-Blind, Placebo Controlled Trial of Simvastatin to Treat Alzheimer Disease
Neurol 77:556-563, Sano, M.,et al, 2011
Efficacy and Safety of Combination Antiplatelet Therapies in Patients with Symptomatic Intracranial Atherosclerotic Stenosis
Stroke 42:2883-2890, Kwon, S.U.,et al, 2011
Decompressive Surgery in Cerebrovenous Thrombosis A Multicenter Registry and a Systematic Review of Individual Patient Data
Stroke 42:2825-2831, Ferro, J.M.,et al, 2011
Chronic Heart Failure and Ischemic Stroke
Stroke 42:2977-2982, Haeusler, K.G.,et al, 2011
Responsive Cortical Stimulation for the Treatment of Medically Intractable Partial Epilepsy
Neurol 77:1295-1304,e79, Morrell, M.J.,et al, 2011
Autoimmune Limbic Encephalitis with GAD Antibodies
The Neurohospitalist 1:178-181, Finelli, P.F., 2011
Routine HIV Screening - What Counts in Evidence-Based Policy?
NEJM 365:1265-1268, Bayer, R. and Oppenheimer G.M., 2011
Sudden, Unexpected Death in Epilepsy
NEJM 365:2902-11, Devinsky, O., 2011
Toxocara Canis Myelitis Clinical Features, Magnetic Resonance Imaging (MRI) Findings, and Treatment Outcome in 17 Patients
Medicine 90:337-343, Jabbour, R.A.,et al, 2011
LMNA Cardiomyopathy:Cell Biology and Genetics Meet Clinical Medicine
Disease Models & Mechanisms 4:562-568, Lu,J.T., et al, 2011
Epstein-Barr Virus Infections of the Nervous System
www.medlink.com, Nov, Amlie-Lefond,C., 2011
Management and Outcome of CSF-JC Virus PCR-negative PML in a Natalizumab-treated Patient with MS
Neurol 77:2010-2016, Kuhle, J.,et al, 2011
Pseudotumor Cerebri: Brief Review of Clinical Syndrome and Imaging Findings
AJNR 32:1986-1993, Degnan, A.J. and Levy L.M., 2011
Cancer Risk Among Patients with Myotonic Muscular Dystrophy
JAMA 306:2480-2486, Gadalla, S.M.,et al, 2011
Antiretroviral Prophylaxis: A Defining Moment in HIV Control
Lancet 378:e23-25, Karim, S.S. and Karim, Q.A., 2011
Infectious Mononucleosis in Adults and Adolescents
UpToDate, May, Aronson,M.D. & Auwaerter,P.G., 2011
5 Versus 10 days of treatment with ceftriaxone for bacterial meningitis in children: a double-blind randomised equivalence study
Lancet 377:1837-1845,1809, Molyneux, E.,et al, 2011
Outcomes and prognostic factors of intracranial unruptured vertebrobasilar artery dissection
Neurol 76:1735-1741, Kim, B.M.,et al, 2011
Rhombencephalitis A Series of 97 Patients
Medicine 90:256-261, Moragas, M.,et al, 2011
Microbleeds are Associated with Subsequent Hemorrhagic and Ischemic Stroke in Healthy Elderly Individuals
Stroke 42:1867-1871, Bokura, H.,et al, 2011
Presentation, Diagnosis, Pathophysiology, and Treatment of the Neurological Features of Sturge-Weber Syndrome
The Neurologist 17:179-184, Comi, A.M., 2011
Primary Central Nervous System Lymphoma in a Patient Treated with Natalizumab
Ann Neurol 69:1060-1062, Phan-Ba, R.,et al, 2011
Clinicopathologic conference, Neurologic form of immune reconstitution inflammatory syndrome (neuro-IRIS), without evidence of concurrent opportunistic infection
NEJM 362:2343-2352, Case 18-2011, 2011
Central Nervous System Lymphoma: Characteristic Findings on Traditional and Advanced Imaging
AJNR 32:984-992, Haldorsen, I.S.,et al, 2011
Treatment of Unruptured Cerebral Aneurysms: Cause for Concern?
AJNR 32:1076-77, Molyneux, A.J., 2011
Patient Outcomes are Better for Unruptured Cerebral Aneurysms Treated at Centers that Preferentially Treat with Endovascular Coiling: A Study of the National Inpatient Sample 2001-2007
AJNR 32:1065-1070, 1076, Brinjiikii, W.,et al, 2011
Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
Lancet 377:2013-2022, Bousser, M.G.,et al, 2011
Are subjects with spondylotic cervical cord encroachment at increased risk of cervical spinal cord injury after minor trauma?
JNNP 82:779-781, Benarik, J.et al, 2011
Encephalitis and antibodies to synaptic and neuronal cell surface proteins
Neurol 77:179-189, Lancaster, E.,et al, 2011
An unusual cause of stroke and hypoxia
BMJ 342:c7200, Bell, S.L. & Eveson, D.J., 2011
Diagnosing Cerebral Aneuryms by Computed Tomographic Angiography: Meta-Analysis
Ann Neurol 69:646-654, Menke, J.,et al, 2011
Mechanisms of Fingolimods Efficacy and Adverse Effects in Multiple Sclerosis
Ann Neurol 69:759-777, Cohen, J.A. & Chun, J., 2011
Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy
Neurol 76:1555-1563, French, J.A.,et al, 2011
Seizure risk from cavernous or arteriovenous malformations
Neurol 76:1548-1554, Josephson, C.B.,et al, 2011
Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force
Eur J Neurol 18:19-27, Titulaer, M.J.,et al, 2011
The King-Devick test as a determinant of head trauma and concussion in boxers and MMA fighters
Neurol 76:1456-1462, Galetta, K.M.,et al, 2011
Concussion
76:e83-e85, Karceski, S., 2011
Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data
Pharmacol Ther 129:185-194, Terry, K.W.,et al, 2011
Post-acute care and secondary prevention after ischaemic stroke
BMJ 342:d2083, McArthur, K.S.,et al, 2011
Pediatric Neurological Complications of 2009 Pandemic Influenza A (H1N1)
Arch Neurol 68:455-462, Kedia, S.,et al, 2011
Prevalence of MRI-defined recent silent ischemia and associated bleeding risk with thrombolysis
Neurol 76:1288-1295, Tisserand, M.,et al, 2011
Cost Efficiency of Anticoagulation With Warfarin to Prevent Stroke in Medicare Beneficiaries With Nonvalvular Atrial Fibrillation
Stroke 42:112-118, Mercaldi,C.J.,et al, 2011
Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association
Stroke 42:227-276, Furie,K.L.,et al, 2011
New Alternative to Warfarin May Help Reduce Stroke Risk in Patients With AF
JAMA 305:25-26, Mitka,M., 2011
Neurocysticercosis in Houston, Texas: An Update
Medicine 90:81-86, Serpa,J.A.,et al, 2011
Cerebral Amyloid Angiopathy Related Inflammation: Three Case Reports and a Review
JNNP 82:20-26, Chung,K.K.,et al, 2011
Apixaban in Patients With Atrial Fibrillation
NEJM 364:806-817, Connolly,S.J.,et al, 2011
Use of Ibuprofen and Risk of Parkinson Disease
Neurol 76:863-869, Gao,X.,et al, 2011
Screening for Fitness to Drive After Stroke: A Systematic Review and Meta-Analysis
Neurol 76:747-756, e35, Devos,H.,et al, 2011
Immune Reconstitution Inflammatory Syndrome in Patients With Multiple Sclerosis Following Cessation of Natalizumab Therapy
Arch Neurol 68:186-191, Miravalle,A.,et al, 2011